Pharmacoeconomic Analysis - The Way to Optimization of Using the Health Budget

Tetiana Nehoda


Reforming the drug supply system requires the introduction of modern scientific approaches to quality management of pharmacotherapy, the main principle of which is the individual selection of the drug taking into account its effectiveness and safety. Introduction: To analyze the literature on the need and feasibility of using pharmacoeconomic methods to provide medicines. Materials and methods: The basis for research is the methods of pharmacoeconomics. Results: The analysis of the data of literature sources was carried out and the necessity of using pharmacoeconomic methods in the field of health care was determined. Conclusions: As a result of the review, it was determined that pharmacoeconomic analysis is an effective method that facilitates the adoption of optimal decisions in the field of drug supply.
Keywords: Arterial hypertension; Health care, Antihypertensive drugs; Form system.

Full Text:



Lebedeva, T (2002) Guarantors of reliable information / T. Lebedeva // Farm. vestn., 13: 5.

Panfilova T (2001) From subjective assessments to ubiquitous clinical and economic research / T. Panfilova // Pharmac. vestn., 39: 5.

Aleshenkova EG (2001) Organizational approaches to conducting pharmacoeconomic research / E.G. Aleschenkova, L.V. Kobzar // Economics. vestn. Pharmacy, (4): 87-89.

Bikmetova, T (2002) Efficiency must be proven / T. Bikmetova // Pharmac. Vestn., 25: 6.

Vorobiev P (2000) A lot has been done, but the main work is still ahead / P. Vorobiev // Pharmac. vestn., 2: 8.

Dremova NB (1993) Organizational and economic aspects of improving drug supply for the population / N.B. Dremova, L.V. Moshkova, A.I. Lukin // Sat. scientific. works M, 54 - 60.

Sapovsky MM (1997) Organizational issues of rational use of medicines on the basis of the territorial formulary system / M.M. Sapovsky // Pharmacy, 2: 22-23.

Yuryeva I (2002) It all starts with standards / I. Yuryev // Pharmaceutical Bulletin, 12: 4.

Shchetinin M (2002) Standards save money / M. Shchetinin // Pharmaceutical Bulletin, 13: 4.

Pharmacoeconomic advantages of using multipurpose monotherapy with tonocardine in elderly patients with concomitant pathology / L.B. Lazebnik, L. Gorilovsky, E. Klimanova, Yu. Konev // Pharmac. vestn. - 2001.- N. 24.- P. 20-21.

Karpov O (2001) To the recommendations of non-prescription drugs based on pharmacoeconomics / O. Karpov // Pharmac. vestn., 31: 15.

Krestinsky Yu K (1999) The concept of pharmacoeconomics as a separate branch of the health care economy / Yu.K. Krestinsky // Pharmac. vestn., 2: 8.

Kobzar LV (2000) Modern concept of pharmacoeconomic research / L.V. Kobzar, E.G. Aleshenkova // Pharmacy, 5-6: 10-12.

Belousov Yu B (1999) Health economics: an introduction to pharmacoeconomics / Yu.B. Belousov // Remedium. 4: З8 - 44.

Krestinsky Yu K (1999) The concept of pharmacoeconomics as a separate branch of the health care economy / Yu.K. Krestinsky // Pharmac. vestn., 2: 8.

Bykov A (2002) Pharmacoeconomics as a tool for harmonious market development / A. Bykov // Remedium. 4: 36-39.

Danilova A (2002) Pharmacoeconomics - the basis for effective management of medical care / A. Danilova // Economics. vestn. Pharmacy, 1: 29-32.

Belkina, and Forms require revision / I. Belkina // Pharmac. vestn. - 2000. - N. 12-P. 2.

Chubarev VN (2000) Pharmaceutical information / V.N. Chubarev.- M, 442.

Kobina S (2000) Pharmacoeconomic research is needed for all participants in the pharmaceutical market / S. Kobina // Pharmac. Vestn., 2: 6.

Sheenko O (2000) Formulary - the basis of rational famacotherapy / O. Sheenko // Pharmac. vestn., 12: 6.


  • There are currently no refbacks.